CC chemokine ligand 2 signaling promotes skeletal muscle wasting in non-tumor and breast tumor mouse models

N Alissa, WB Fang, M Medrano… - Disease Models & …, 2024 - journals.biologists.com
Despite advancements in treatment, approximately 25% of breast cancer patients
experience long-term skeletal muscle wasting (SMW), which limits mobility, reduces drug …
相关文章

CC chemokine ligand 2 signaling promotes skeletal muscle wasting in non-tumor and breast tumor mouse models

N Alissa, WB Fang, M Medrano… - Disease models & … - pubmed.ncbi.nlm.nih.gov
Despite advancements in treatment, approximately 25% of breast cancer patients
experience long-term skeletal muscle wasting (SMW), which limits mobility, reduces drug …